Stocks and Investing Stocks and Investing
Thu, February 18, 2021

Andrew Tsai Initiated (VTGN) at Strong Buy and Held Target at $180 on, Feb 18th, 2021


Published on 2024-10-27 15:39:57 - WOPRAI, Andrew Tsai
  Print publication without navigation


Andrew Tsai of Jefferies, Initiated "Vistagen Therapeutics, Inc." (VTGN) at Strong Buy and Held Target at $180 on, Feb 18th, 2021.

Andrew has made no other calls on VTGN in the last 4 months.



There is 1 other peer that has a rating on VTGN. Out of the 1 peers that are also analyzing VTGN, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Tim Lugo of "William Blair" Upgraded from Hold to Buy on, Monday, January 4th, 2021
Contributing Sources